Acorah Software Products - Accounts Production 16.5.460 false true 30 November 2023 1 December 2022 false 1 December 2023 30 November 2024 30 November 2024 11676596 Mr Waseem Hussain iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11676596 2023-11-30 11676596 2024-11-30 11676596 2023-12-01 2024-11-30 11676596 frs-core:CurrentFinancialInstruments 2024-11-30 11676596 frs-core:Non-currentFinancialInstruments 2024-11-30 11676596 frs-core:ShareCapital 2024-11-30 11676596 frs-core:RetainedEarningsAccumulatedLosses 2024-11-30 11676596 frs-bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 11676596 frs-bus:FilletedAccounts 2023-12-01 2024-11-30 11676596 frs-bus:SmallEntities 2023-12-01 2024-11-30 11676596 frs-bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 11676596 frs-bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 11676596 frs-bus:Director1 2023-12-01 2024-11-30 11676596 frs-countries:EnglandWales 2023-12-01 2024-11-30 11676596 2022-11-30 11676596 2023-11-30 11676596 2022-12-01 2023-11-30 11676596 frs-core:CurrentFinancialInstruments 2023-11-30 11676596 frs-core:Non-currentFinancialInstruments 2023-11-30 11676596 frs-core:ShareCapital 2023-11-30 11676596 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30
Registered number: 11676596
WSH Biomedical Limited
Financial Statements
For The Year Ended 30 November 2024
Ingenious Accountants Ltd
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 11676596
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 2,273 5,052
Cash at bank and in hand 591 406
2,864 5,458
Creditors: Amounts Falling Due Within One Year 5 (2,743 ) (2,560 )
NET CURRENT ASSETS (LIABILITIES) 121 2,898
TOTAL ASSETS LESS CURRENT LIABILITIES 121 2,898
Creditors: Amounts Falling Due After More Than One Year 6 (2,200 ) (4,400 )
NET LIABILITIES (2,079 ) (1,502 )
CAPITAL AND RESERVES
Called up share capital 7 1 1
Profit and Loss Account (2,080 ) (1,503 )
SHAREHOLDERS' FUNDS (2,079) (1,502)
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Waseem Hussain
Director
2nd September 2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
WSH Biomedical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11676596 . The registered office is Ingenious Accountants, 74 Corbett Road, London, E17 3JZ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
4. Debtors
2024 2023
£ £
Due within one year
Other debtors 2,273 5,052
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Bank loans and overdrafts 2,383 2,200
Accruals and deferred income 360 360
2,743 2,560
6. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 2,200 4,400
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1 1
Page 2